Bio Essence Corp
corporate_fare Company Profile
Bio Essence Corp (OTC:BIOE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 7 items for BIOE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for BIOE spans 10-Q, PRE 14C, 8-K/A, 8-K.
Recent high-impact activity:
- Bio Essence Q3 Swings to $150K Loss; Going Concern and Weak Controls Reaffirmed
- Bio Essence Creates 10,000-Vote Preferred Class via Written Consent
- Bio Essence Q2 Revenue Jumps 207% but Going Concern and Control Weaknesses Persist
- Bio Essence Finalizes MediFlow AI Acquisition, Issues 7M Shares at $0.50
- Q1 Profit Turnaround Amidst Going Concern, Dilutive Offerings, and Control Weaknesses
Financial Snapshot
Short Interest & Short Volume
2.11 days to coverFINRA reported short interest of 7,738 shares in BIOE as of the October 30, 2026 settlement, a 2067.5% increase from the prior period — about 2.1 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.